Traditional studies have ascribed the chemoresistance of glioma to GSCs as a result of the higher expression of chemoresistance-related proteins, such as ABCG2 and MGMT3, 8, 11, 23–25. This evidence concerns the gene ABCG2 and central nervous system cancer.